Pirh2 modulates amyloid‐β aggregation through the regulation of glucose‐regulated protein 78 and chaperone‐mediated signaling
Journal of Cellular Physiology · 2023
DOI: 10.1002/jcp.31134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2023. Verfasst von Abhishek Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Endoplasmic Reticulum Chaperone BiP, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Science and Engineering Research Board, Indian Council of Medical Research.
Abstract (Originalsprache)
Amyloid‐β (Aβ) protein aggregation in the brain is a pathological hallmark of Alzheimer's disease (AD) however, the underlying molecular mechanisms regulating amyloid aggregation are not well understood. Here, we studied the propitious role of E3 ubiquitin ligase Pirh2 in Aβ protein aggregation in view of its regulatory ligase activity in the ubiquitin‐proteasome system employing both cellular and sporadic rodent models of AD. Pirh2 protein abundance was significantly increased during Streptozotocin (STZ) induced AD conditions, and transient silencing of Pirh2 significantly inhibited the Aβ aggregation and modified the dendrite morphology along with the substantial decrease in choline level in the differentiated neurons. MALDI‐TOF/TOF, coimmunoprecipitation, and UbcH7‐linked in vitro ubiquitylation analysis confirmed the high interaction of Pirh2 with chaperone GRP78. Furthermore, Pirh2 silencing inhibits the STZ induced altered level of endoplasmic reticulum stress and intracellular Ca 2+ levels in neuronal N2a cells. Pirh2 silencing also inhibited the AD conditions related to the altered protein abundance of HSP90 and its co‐chaperones which may collectively involve in the reduced burden of amyloid aggregates in neuronal cells. Pirh2 silencing further stabilized the nuclear translocation of phospho‐Nrf2 and inhibited the altered level of autophagy factors. Taken together, our data indicated that Pirh2 is critically involved in STZ induced AD pathogenesis through its interaction with ER‐chaperone GRP78, improves the neuronal connectivity, affects the altered level of chaperones, co‐chaperones, & autophagic markers, and collectively inhibits the Aβ aggregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, India.
- Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, India.
ORCID-Profile: Sarika Singh
Förderung
- Science and Engineering Research Board
- Indian Council of Medical Research
Zitieren
APA
Singh, A., Tiwari, S., & Singh, S. (2023). Pirh2 modulates amyloid‐β aggregation through the regulation of glucose‐regulated protein 78 and chaperone‐mediated signaling. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31134
Vancouver
Singh A, Tiwari S, Singh S. Pirh2 modulates amyloid‐β aggregation through the regulation of glucose‐regulated protein 78 and chaperone‐mediated signaling. Journal of Cellular Physiology. 2023. doi:10.1002/jcp.31134
BibTeX
@article{Singh2023,
author = {Singh, Abhishek and Tiwari, Shubhangini and Singh, Sarika},
title = {Pirh2 modulates amyloid‐β aggregation through the regulation of glucose‐regulated protein 78 and chaperone‐mediated signaling},
journal = {Journal of Cellular Physiology},
year = {2023},
doi = {10.1002/jcp.31134}
}
EUVIMED